Table 1.

Effect of ifosfamide and BSO on DC viability



Cell labeling, %

Annexin V-PI−
Annexin V+
Annexin V+PI+
PI+
Control   81.8 ± 5.7   8.5 ± 2   8 ± 3.8   1.5 ± 0.9  
4-OH-IF   80 ± 6.4   9.6 ± 1.8   9 ± 4.5   1.2 ± 0.6  
BSO   82.3 ± 5.3   8.47 ± 1.6   7.5 ± 3.5   1.7 ± 0.5  
Control*  81 ± 16   12 ± 10   10 ± 9   7 ± 6  
4-OH-IF*
 
84 ± 13
 
9 ± 8
 
10 ± 8
 
6 ± 4
 


Cell labeling, %

Annexin V-PI−
Annexin V+
Annexin V+PI+
PI+
Control   81.8 ± 5.7   8.5 ± 2   8 ± 3.8   1.5 ± 0.9  
4-OH-IF   80 ± 6.4   9.6 ± 1.8   9 ± 4.5   1.2 ± 0.6  
BSO   82.3 ± 5.3   8.47 ± 1.6   7.5 ± 3.5   1.7 ± 0.5  
Control*  81 ± 16   12 ± 10   10 ± 9   7 ± 6  
4-OH-IF*
 
84 ± 13
 
9 ± 8
 
10 ± 8
 
6 ± 4
 

Immature DCs derived from monocytes were treated with 4-OH-IF (100 μM) on day 8 for 90 minutes or with BSO (5 mM) for 24 hours on day 7 and were tested for viability. DCs were also incubated with 4-OH-IF for 90 minutes and tested for viability 48 hours later.

*

Cells were then washed and incubated with FITC-conjugated Annexin V for 10 minutes at room temperature. PI (1 μg/mL) was added before flow cytometry analysis. Annexin V+ staining indicates cells in early apoptosis, Annexin V+PI+ staining indicates late apoptosis, and PI+ staining alone indicates necrotic cells. Data represent the mean ± SD of percentage positive cells in each quadrant of a dot plot analysis from 4 different donors.

Close Modal

or Create an Account

Close Modal
Close Modal